13th International Campylobacter/Helicobacter workshop

描述(由申请人提供)： 我们计划于2005年9月4日至8日在澳大利亚昆士兰州黄金海岸举办第13届弯曲杆菌、幽门螺杆菌及相关生物国际研讨会。在过去的21年里，我们在世界各地与该领域的世界领先权威举行了会议。这个两年一度的研讨会始于1981年，是一个国际论坛，致力于增进我们对这组迷人的细菌病原体的了解。空肠弯曲杆菌现在已被确定为发达国家和发展中国家细菌性腹泻的主要原因。现在已知空肠弯曲菌也是格林-巴利综合征的主要原因之一，并继续吸引着全世界的密集研究。由于空肠弯曲菌的基因组序列已经获得多年，这些信息为弯曲菌致病的基因组学和蛋白质组学研究提供了新的机会。1983年在布鲁塞尔举行的第二次研讨会上，幽门螺杆菌(当时名为幽门弯曲菌)被引入世界，开启了胃十二指肠疾病的微生物学革命。幽门螺杆菌与胃炎、消化性溃疡和胃癌的关系现已得到普遍认可。随着许多科学家和临床医生为此而努力，对涉及幽门螺杆菌的疾病过程的了解以及预防或控制它的手段似乎是触手可及的。研讨会将包括生物信息学和基因组学、遗传学、发病机制、免疫学、诊断和流行病学、抗微生物疗法、新出现的病原体以及格林-巴利综合征和反应性关节炎等免疫后遗症的会议。这些国际研讨会为来自不同学科的临床医生和科学家交流信息、制定研究战略和更新有关这些具有极端医学重要性的微生物的最新信息提供了理想的机会。

DESCRIPTION (provided by applicant): We propose to host the 13th International Workshop on Campylobacter, Helicobacter & Related Organisms (CHRO) from September 4-8, 2005 in Gold Coast, Queensland, Australia. Over the past 21 years, our meetings have been held around the world with the world's leading authorities in the field. This biennial workshop, started in 1981, is an international forum dedicated to enhancing our knowledge of this fascinating group of bacterial pathogens. Campylobacter jejuni is now firmly established as the major cause of bacterial diarrhea in both developed and developing countries. C. jejuni is now known to also be one of the major causes of Guillain-Barre Syndrome and continues attracting intense investigation worldwide. Now that the genome sequence of C. jejuni has been available for a number of years, this information has provided an avenue for new research opportunities in both genomics and proteomics of Campylobacter pathogenesis. At the 2nd workshop in Brussels in 1983, Helicobacter pylori (then named Campylobacter pylori) was introduced to the world and the microbiological revolution of gastroduodenal disease began. The association of H. pylori with gastritis, peptic ulcers and gastric carcinoma is now universally recognized. An understanding of the disease process involving H. pylori and hopefully, the means to prevent or control it appears to be within reach as a great many scientists and clinicians are striving towards this end. The workshop will include sessions on bioinformatics and genomics, genetics, pathogenesis, immunology, diagnostics and epidemiology, antimicrobial therapy, new and emerging pathogens, and immune sequelae such as Guillain-Barre syndrome and reactive arthritis. These international workshops provide the ideal opportunity for clinicians and scientists from a variety of disciplines to exchange information, formulate research strategies and update themselves on the latest information on these microorganisms of extreme medical importance.